Can COVID-19 cause atypical forms of pityriasis rosea refractory to conventional therapies?

J Med Virol. 2022 Apr;94(4):1292-1293. doi: 10.1002/jmv.27535. Epub 2021 Dec 31.

Authors

Fabrizio Martora¹, Vincenzo Picone¹, Luigi Fornaro¹, Gabriella Fabbrocini¹, Claudio Marasca¹

Affiliation

¹ Department of Clinical Medicine and Surgery, Section of Dermatology, University Hospital Federico II of Naples, Italy.

PMID: 34931329
DOI: 10.1002/jmv.27535

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19*
Humans
Pityriasis Rosea* / diagnosis
Pityriasis Rosea* / drug therapy
SARS-CoV-2
Skin